Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Dec 2024 for EUROBIO-SCIENTIFIC, €88.3M. Read the official filing
Filing timeline
BuySaleEurobioNext
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+9.3%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -13.7%Entry €18.19 · Close at T+365 €15.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
EurobioNext: trading record in brief
EurobioNext, listed as board member, appears in our data through filings on Eurobio-Scientific shares, published by AMF. The record holds 3 filings, for trades running from 8 September 2022 to 29 November 2024.
Every open-market trade on record is a purchase: 2 purchases worth €5.5M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 6 December 2024 with a transaction (€88.3M) in Eurobio-Scientific. The latest purchase dates back some time: it was published 1,496 days ago, on 12 September 2022. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from AMF disclosures alone and does not predict where the share price will go.
Companies and markets linked to EurobioNext
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,488,265 shares@ €25.3094.2% of flowActionEuronext Growth ParisISIN FR00132409342024DD1010001
28,100 shares@ €17.640.5% of flowActionEuronext Growth ParisISIN FR00132409342022DD860355
Canonical exit: 7 Dec 2022 (T+90)
281,000 shares@ €17.645.3% of flowActionEuronext Growth ParisISIN FR00132409342022DD860457
Canonical exit: 7 Dec 2022 (T+90)
3 of 3 declarations
